ET-901 is under clinical development by EdiGene and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma). According to GlobalData, ...
The protease mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) is a signaling protein with both molecular ...
We report herein a case of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma in a patient receiving antithyroid drug therapy for Graves' disease. A 75-year-old woman first presented with ...
Hence to elucidate the potential role of this chemokine and its receptor in human gut associated lymphoid tissue (GALT), we analysed their expression in normal intestine and ulcerative colitis (UC).
with a broad range of specificities reflecting both maternal immunologic memory and antigenic stimulation of maternal mucosal associated lymphoid tissue. Secretory IgA is resistant to degradation ...
With rare exceptions like the oral polio vaccine and intranasal vaccines against influenza, the majority of immunizations are ...
BP-1002 is under clinical development by Bio-Path and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData, Phase I drugs for Cutaneous T-Cell Lymphoma have an 84% phase ...
So how might α-GalCer function as a mucosal adjuvant? In naive mice, very few NKT cells are present in the nasopharynx-associated lymphoid tissue (NALT) and regional cervical lymph nodes (CLNs ...
1 Departments of Pathology and Gastroenterology, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi-machi, Kawachi-gun, Tochigi, Japan 2 Department of Pathology, Jichi Medical School, 3311-1 ...
are extra-nodal structures that are formed in-situ in non-lymphoid tissues and support the generation of immune responses outside of the secondary lymphoid organs (SLOs). TLSs have been shown to have ...
Finally, administration of lipopeptide vaccines to mucosal surfaces, will probably allow the efficient uptake of antigen by dendritic cells, which are abundant in the associated lymphoid tissues. This ...